Please login to the form below

Not currently logged in
Email:
Password:

Caelyx

This page shows the latest Caelyx news and features for those working in and with pharma, biotech and healthcare.

NICE recommends two drugs for ovarian cancer but rejects three

NICE recommends two drugs for ovarian cancer but rejects three

NICE recommends two drugs for ovarian cancer but rejects three. Paclitaxel and Caelyx given preliminary nod. ... Both paclitaxel and Caelyx (pegylated liposomal doxorubicin hydrochloride) are recommended as monotherapy and also in combination with

Latest news

More from news
Approximately 3 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics